6) Pediatric ARDs applications: While CD19 CAR-T cells have shown promise in pediatric SLE and juvenile dermatomyositis (57), their efficacy in other childhood chronic inflammatory rheumatic diseases remains unexplored. This evidence concerns the gene CD19 and systemic lupus erythematosus.